14.2 Pediatric Respiratory and Infectious Illnesses

14.2 Pediatric Respiratory and Infectious Illnesses

Respiratory disorders represent the most frequent cause of acute hospitalization and emergency department presentation in the pediatric population. The infant and young child possess unique anatomical and physiological airway vulnerabilities: a narrow subglottic airway diameter, a high, anteriorly positioned larynx, a large tongue relative to the oral cavity, compliant cartilaginous ribs positioned horizontally, and a high reliance on diaphragmatic excursion. According to Poiseuille's Law, airway resistance is inversely proportional to the fourth power of the airway radius (Resistance proportional to 1 / radius^4); thus, a mere 1 mm of circumferential mucosal edema in an infant's 4 mm subglottic airway reduces cross-sectional area by 75% and increases airway resistance 16-fold, rapidly precipitating severe respiratory distress and decompensation.

Acute Laryngotracheobronchitis (Croup) vs. Acute Epiglottitis

Differentiating viral croup from acute bacterial epiglottitis is among the most vital diagnostic distinctions in emergency pediatric nursing, as inappropriate clinical actions in epiglottitis can induce fatal airway obstruction.

Acute Laryngotracheobronchitis (Viral Croup)

• Etiology: Parainfluenza virus (types 1, 2, and 3) causes > 75% of cases; secondary causes include Respiratory Syncytial Virus (RSV), adenovirus, and human metapneumovirus. Typically affects children aged 6 months to 3 years during late autumn and winter.
• Pathophysiology: Viral invasion of the upper respiratory tract triggers inflammation, hyperemic erythema, and mucosal edema localized to the subglottic region, specifically the larynx, trachea, and subglottic tissue beneath the vocal cords.
• Clinical Presentation:
  • Prodromal upper respiratory infection (rhinorrhea, low-grade fever < 38.5°C) lasting 1 to 3 days.
  • Gradual emergence of a characteristic harsh, brassy, metallic "barking seal" cough.
  • Inspiratory stridor that worsens with crying, agitation, or supine positioning.
  • Hoarseness, tachypnea, and suprasternal retractions.
  • Symptoms characteristically peak during nighttime hours and improve during daytime.
• Diagnostic Radiography: Anteroposterior (AP) soft-tissue neck radiograph reveals symmetrical subglottic narrowing known as the classic "Steeple Sign" or "pencil-point sign" (radiography is not mandatory if clinical features are unequivocal).
• Evidence-Based Medical & Nursing Management:
  • Mild Croup (Barking cough, hoarseness, NO stridor at rest): Outpatient supportive management; cool humidified mist (exposure to cool night air or bathroom steam); oral hydration; parental comfort.
  • Moderate to Severe Croup (Stridor at rest, intercostal/suprasternal retractions, agitation):
    • Dexamethasone: Administer a single dose of 0.6 mg/kg (maximum 16 mg) orally, intramuscularly, or intravenously. Dexamethasone is a potent glucocorticoid that reduces subglottic laryngeal edema within 2 to 3 hours, with prolonged anti-inflammatory effects lasting 72 hours.
    • Nebulized Racemic Epinephrine (2.25% solution, 0.05 mL/kg, maximum 0.5 mL in 2.5 mL normal saline): Administered via nebulizer driven by oxygen for moderate-to-severe stridor at rest. Epinephrine stimulates local mucosal alpha1-adrenergic receptors, inducing profound arteriolar vasoconstriction, decreasing capillary hydrostatic pressure, and rapidly shrinking mucosal edema within 10 to 30 minutes.
    • CRITICAL NURSING DIRECTIVE: THE REBOUND EFFECT: The mucosal vasoconstrictive action of racemic epinephrine is transient, dissipating within 2 hours. Because the underlying viral inflammatory edema persists, the child may develop rebound stridor and severe airway obstruction 2 to 4 hours post-administration. The nurse must monitor the child closely in the clinical setting for at least 3 to 4 hours following racemic epinephrine nebulization before considering safe discharge.

Acute Epiglottitis (Supraglottic Airway Emergency)

• Etiology: Bacterial invasion, historically dominated by Haemophilus influenzae type b (Hib). Widespread Hib vaccination has drastically lowered incidence, but cases still arise from Streptococcus pyogenes (Group A Strep), Streptococcus pneumoniae, and Staphylococcus aureus (including MRSA). Peak incidence occurs between 2 and 7 years of age.
• Pathophysiology: Fulminant, invasive bacterial cellulitis of the supraglottic structures, specifically the epiglottis, arytenoids, aryepiglottic folds, and ventricular bands. Massive edematous swelling transforms the epiglottis into a swollen, cherry-red mass that mechanically blocks the laryngeal inlet during inspiration.
• Clinical Presentation:
  • Abrupt, explosive onset progressing within hours from a sore throat to lethal respiratory failure.
  • High fever (> 39.0°C / 102.2°F), severe prostration, toxic, pale, and anxious appearance.
  • Absence of a barking seal cough (cough is rare or absent).
  • The Classic "4 Ds":
    1. Drooling: Profuse loss of saliva because swallowing is excruciatingly painful.
    2. Dysphagia: Inability or refusal to swallow liquids or solids.
    3. Dysphonia: Muffled, weak, throaty speech resembling a "hot potato" voice.
    4. Distressed Inspiratory Stridor: High-pitched, late-stage stridor accompanied by air hunger.
  • The Tripod Posture: The child instinctively sits bolt upright, leaning forward with arms braced on knees, chin hyperextended, neck extended, and mouth wide open with tongue protruding to maximize airway diameter.
• THE CARDINAL NURSING RULE: NEVER EXAMINE THE PHARYNX:
  • NEVER use a tongue blade, swab, or indirect mirror to visualize the posterior pharynx.
  • NEVER force the child into a supine or recumbent position.
  • NEVER attempt venipuncture, IV placement, or arterial punctures prior to definitive airway control.
  • NEVER separate the child from the parents or cause undue agitation or crying.
  • Pathophysiological Rationale: Tactile stimulation or crying-induced laryngeal agitation triggers immediate, irreversible reflex laryngospasm, slamming the swollen supraglottic tissues shut and precipitating complete, fatal airway occlusion within seconds.
• Emergency Nursing & Interprofessional Protocol:
  1. Maintain the child in an upright, comforting position on the parent's lap.
  2. Administer humidified 100% blow-by oxygen held gently near the face by the parent.
  3. Immediately mobilize the Emergency Airway Team (pediatric anesthesiologist, pediatric otolaryngologist, and critical care intensivist).
  4. Transfer the patient directly to the Operating Room (OR) or pediatric ICU; keep emergency tracheostomy and rigid bronchoscopy equipment immediately available at the bedside.
  5. Perform controlled endotracheal intubation under general inhalation anesthesia in the OR.
  6. Establish peripheral IV access, draw blood cultures, and initiate empirical IV antibiotics (e.g., Ceftriaxone 50 to 100 mg/kg/day or Cefotaxime plus Vancomycin) and IV corticosteroids ONLY AFTER the airway is definitively secured with an endotracheal tube.

Comparative Diagnostic Matrix: Croup vs. Acute Epiglottitis

Bronchiolitis and Respiratory Syncytial Virus (RSV)

Epidemiology & Pathophysiology

Bronchiolitis is an acute viral lower respiratory tract infection affecting the small bronchioles. It represents the leading cause of hospitalization in infants younger than 1 year, with peak incidence between 2 and 6 months of age. Respiratory Syncytial Virus (RSV) accounts for 70% to 85% of cases, with human rhinovirus, metapneumovirus, and bocavirus responsible for the remainder.

RSV infects the ciliated epithelial cells lining the small bronchiolar passages, causing extensive cell necrosis, syncytia formation (large multinucleated cell masses), and severe submucosal edema. Abundant intraluminal cellular debris and thick, tenacious mucus form dense plugs within the bronchioles. Because air entry during inspiration is actively facilitated by thoracic expansion, air passes around partial obstructions; however, passive bronchiolar narrowing during expiration traps air distally. This mechanism generates alveolar hyperinflation, air trapping, localized atelectasis, ventilation-perfusion mismatch, and hypoxemia.

Infection Control: Contact and Droplet Precautions

RSV is transmitted via large respiratory droplets and contaminated hands or fomites. The virus survives on non-porous surfaces (countertops, crib rails, stethoscopes) for up to 6 hours, and on porous surfaces for up to 2 hours. Hospitalized infants must be placed on Contact and Droplet Precautions:

• Private room or cohorting with other laboratory-confirmed RSV patients.
• Healthcare personnel must don a gown and gloves upon room entry, plus a surgical mask with eye protection when within 3 feet (1 meter) of the infant.
• Dedicated single-patient medical equipment (stethoscope, blood pressure cuff, thermometer).

Clinical Manifestations & Progression

• Early Prodromal Phase (Days 1 to 2): Clear, copious rhinorrhea ("snots"), low-grade fever, sneezing, reduced appetite, and mild intermittent cough.
• Acute Lower Airway Phase (Days 3 to 5): Persistent paroxysmal cough, marked tachypnea (respiratory rate 60 to 80+ breaths/min), diffuse high-pitched expiratory wheezing, coarse crackles, prominent intercostal, subcostal, and suprasternal retractions, nasal flaring, and prolonged expiratory phase. Irritability and difficulty feeding due to dyspnea.
• Severe / Decompensated Phase: Sustained tachypnea > 70 breaths/min, grunting (compensatory positive end-expiratory pressure generation), marked lethargy, central cyanosis, oxygen desaturation (SpO2 < 90%), and apnea (especially in premature infants or neonates < 2 months old).

Evidence-Based Nursing Interventions & Supportive Care

1. Gentle Airway Clearance: Routine deep tracheal suctioning is avoided as it induces mucosal trauma and edema. Instead, perform gentle nasal and oral suctioning using a bulb syringe or soft silicone catheter with wall suction (80 to 100 mmHg) immediately before feedings and before sleep to relieve mechanical upper airway obstruction.
2. Humidified Oxygen Therapy: Administer warmed, humidified oxygen via nasal cannula to maintain oxygen saturation (SpO2) at >= 90% to 92%.
3. Positioning: Elevate the head of the bed 30 to 40 degrees with the infant's neck maintained in a neutral or slightly extended sniffing position.
4. Hydration & Enteral Safety: Assess respiratory rate continuously. If the infant's respiratory rate is > 60 breaths/min, oral bottle or breast feedings are strictly held (NPO) due to the extreme risk of aspiration during dyspnea. Hydration is maintained via intravenous maintenance fluids (isotonic crystalloids) or small-volume continuous nasogastric tube feeds.
5. Medication Stewardship: The American Academy of Pediatrics (AAP) explicitly recommends against the routine use of bronchodilators (albuterol), systemic corticosteroids, or antibacterial agents, as they do not shorten hospital stay or alter disease progression. Hypertonic saline (3%) nebulization may be utilized in inpatient settings to enhance mucociliary clearance.
6. Monoclonal Antibody Prophylaxis: Palivizumab (Synagis) is a recombinant humanized monoclonal antibody directed against the RSV F (fusion) glycoprotein. It provides passive immunity and is administered at 15 mg/kg IM monthly (maximum 5 doses) during peak RSV season (November to March) for high-risk populations: infants born at < 29 weeks 0 days gestation, infants with hemodynamically significant congenital heart disease, or infants with chronic lung disease of prematurity requiring supplemental oxygen.

Pediatric Asthma: Pathophysiology, Monitoring & Inhalation Technique

Asthma is the most prevalent chronic pediatric disease, characterized by chronic bronchial airway inflammation, hyperresponsiveness to environmental and viral triggers, and variable airflow obstruction secondary to bronchospasm, mucosal edema, and mucus hypersecretion.

Peak Expiratory Flow Rate (PEFR) Action Zones

The child's personal best peak flow reading (measured during asymptomatic baseline) guides the Asthma Action Plan:

• Green Zone (80% to 100% of Personal Best): Indicates optimal control. The child is asymptomatic, sleeps undisturbed, and participates fully in physical play. Nursing instruction: Continue routine daily controller medications (e.g., daily inhaled corticosteroid).
• Yellow Zone (50% to 79% of Personal Best): Indicates acute airway narrowing or impending exacerbation. Manifests as coughing, mild wheezing, chest tightness, or nighttime awakenings. Nursing instruction: Administer prescribed quick-relief short-acting beta2-agonist (SABA, e.g., albuterol 2 to 4 puffs); re-measure peak flow after 20 to 30 minutes. If readings remain in the yellow zone, contact the healthcare provider and initiate stepped therapy (e.g., short course of oral systemic corticosteroids).
• Red Zone (< 50% of Personal Best): Medical Emergency. Severe airway bronchoconstriction with severe dyspnea, retractions, nasal flaring, and difficulty speaking. Nursing instruction: Administer quick-relief SABA nebulizer or MDI immediately, administer oral systemic corticosteroid, and seek emergency department medical evaluation without delay.

Metered-Dose Inhaler (MDI) Administration: Valved Holding Chambers

In pediatric patients, an MDI must NEVER be actuated directly into the mouth without a spacer. Without a valved holding chamber (spacer), up to 80% to 90% of the aerosolized medication impacts against the posterior pharyngeal wall and is swallowed, causing systemic side effects while leaving less than 10% to reach the lower pulmonary tree. A valved spacer suspends the aerosolized micro-droplets, slowing velocity and allowing deep alveolar inhalation.

Step-by-Step Pediatric MDI + Valved Spacer Administration Protocol:
1. Shake the MDI canister vigorously for 5 full seconds.
2. Remove protective caps; insert MDI firmly into the spacer chamber port.
3. Fit the mask snugly over the child's nose and mouth (or have child seal lips
   tightly around the mouthpiece without blocking it with teeth or tongue).
4. Instruct the child to exhale completely.
5. Actuate EXACTLY ONE PUFF into the spacer chamber.
6. Instruct the child to inhale slowly and deeply over 3 to 5 seconds (if using a mask,
   allow 5 to 6 normal tidal breaths; if whistle sounds, inhalation is too rapid!).
7. Have the child hold their breath for 10 full seconds to allow alveolar settling.
8. Wait 1 full minute before administering a second puff of medication.

Oral Care after Inhaled Corticosteroids (ICS): Following administration of inhaled corticosteroids (e.g., fluticasone, budesonide), the nurse must instruct the child to rinse their mouth thoroughly with water, gargle, and spit it out (or wipe the oral mucosa with a damp cloth in young children). Swallowing or retaining steroid residue in the mouth alters oral microflora and induces local immunosuppression, predisposing to oropharyngeal candidiasis (thrush) and dysphonia.

Common Childhood Exanthems: Measles & Chickenpox

1. Measles (Rubeola)

• Infectious Agent & Transmission: Paramyxovirus. Transmitted via airborne droplet nuclei or direct contact with nasal/throat secretions. Extremely contagious (secondary attack rate > 90% in non-immune contacts); virus remains viable in suspended air currents for up to 2 hours after an infected patient vacates the room.
• Infection Control: Strict Airborne Precautions in a negative-pressure Airborne Infection Isolation Room (AIIR); healthcare workers must wear fit-tested N95 respirators or PAPRs upon room entry.
• Prodromal Phase (Days 1 to 3): Escalating high fever (often > 40.0°C / 104.0°F), marked lethargy, and the pathognomonic "Three Cs":
  1. Cough: Severe, hacking, non-productive cough.
  2. Coryza: Profuse clear rhinorrhea and nasal congestion.
  3. Conjunctivitis: Marked bilateral ocular erythema, edema, lacrimation, and severe photophobia.
• Pathognomonic Enanthem: Koplik Spots: Tiny, pinpoint, bluish-white or gray specks surrounded by an erythematous ring located on the buccal mucosa opposite the lower molars. Appear 1 to 2 days prior to the cutaneous rash and fade within 48 hours.
• Exanthematous Phase (Days 3 to 7): Erythematous, confluent, maculopapular rash that originates at the hairline, behind the ears, and over the forehead, then spreads cephalocaudally downward over the face, neck, trunk, upper extremities, and finally the lower extremities and feet. Fades in the identical order of appearance, leaving a fine brownish desquamation.
• Therapeutic Nursing Interventions: Dim room lighting and avoid direct sunlight to ease photophobia; administer antipyretics; provide cool humidification; administer Vitamin A supplementation (single oral dose of 200,000 IU for children >= 1 year, repeated the following day). Vitamin A accelerates epithelial repair, preserves retinal integrity, and significantly reduces measles-related mortality, pneumonia, and blindness.

2. Chickenpox (Varicella Zoster Virus - VZV)

• Transmission & Precautions: Highly contagious herpesvirus transmitted via airborne droplet nuclei from respiratory secretions and direct contact with vesicular fluid. Mandates Airborne AND Contact Precautions.
• Period of Communicability: Highly infectious from 1 to 2 days prior to the onset of the rash until ALL lesions have completely crusted and dried (typically 6 to 7 days). Once every vesicle has formed a hard, dry scab, transmission ceases and isolation can be discontinued.
• Cutaneous Morphology & Evolution: Eruptions begin predominantly on the scalp, neck, and trunk, subsequently spreading centrifugally to the face and extremities. Lesions progress rapidly through distinct stages: erythematous macules -> papules -> clear, highly pruritic fluid-filled vesicles surrounded by an erythematous base (the classic "dewdrops on a rose petal") -> umbilicated cloudy pustules -> crusted scabs. Hallmark feature: lesions in ALL stages of development are present simultaneously in the same anatomical area.
• Nursing Care: Colloidal oatmeal baths; application of calamine lotion; oral antihistamines (diphenhydramine); keep the child's fingernails trimmed short and clean, or apply soft cotton mittens to prevent scratching. Scratching excoriates vesicles, introducing skin flora and causing secondary bacterial superinfections (Group A Streptococcal cellulitis, impetigo, necrotizing fasciitis) and permanent scarring.
• CRITICAL CONTRAINDICATION: NEVER GIVE ASPIRIN: Salicylates are strictly prohibited during varicella and influenza infections due to the fatal risk of Reye's syndrome.

Pediatric Fever Management & Febrile Seizures

Clinical Definition & Pathophysiology of Pediatric Fever

Fever is defined as a regulated elevation of the core body temperature to >= 38.0°C (100.4°F), orchestrated by the anterior hypothalamus in response to endogenous pyrogens (interleukin-1, interleukin-6, tumor necrosis factor) released during infection. Fever enhances phagocytosis, inhibits viral replication, and stimulates T-cell proliferation. The primary goal of antipyretic administration is to alleviate physical distress, reduce metabolic and oxygen consumption demands, and relieve parental anxiety, rather than achieving complete normothermia.

Weight-Based Antipyretic Pharmacotherapy

Pathophysiology of Reye's Syndrome

Reye's syndrome is a fulminant biphasic condition characterized by generalized mitochondrial dysfunction. Salicylate metabolites disrupt mitochondrial beta-oxidation and oxidative phosphorylation, inducing acute non-inflammatory cerebral edema with surging intracranial pressure (ICP), paired with microvesicular hepatic fatty infiltration (steatosis). The child develops sudden, recurrent, pernicious vomiting, progressive lethargy, hyperventilation, delirium, stupor, loss of deep tendon reflexes, severe hypoglycemia, elevated serum transaminases (AST/ALT), marked hyperammonemia, and fatal cerebral herniation.

Non-Pharmacological Antipyretic Comfort Measures

• Dress the febrile child in a single layer of lightweight, breathable clothing and maintain room temperature at 21°C to 22°C (70°F to 72°F).
• Offer frequent small sips of cool fluids to replenish insensible water losses.
• AVOID Cold-Water Baths, Ice Baths, and Isopropyl Alcohol Rubs: Plunging a child into cold water or applying ice causes intense discomfort and cutaneous vasoconstriction, while shivering dramatically accelerates endogenous heat production, driving core body temperature higher. Rubbing alcohol is readily absorbed through the vascular pediatric dermis, precipitating severe isopropyl alcohol poisoning, metabolic acidosis, and coma.

Pediatric Febrile Seizures

• Definition: Benign generalized tonic-clonic convulsions occurring in infants and young children aged 6 months to 5 years (peak incidence 14 to 18 months) in association with a rapid spike in core temperature to >= 38.0°C (100.4°F), in the absence of central nervous system infection (meningitis, encephalitis), metabolic derangement, or prior afebrile seizures.
• Simple vs. Complex:
  • Simple Febrile Seizure (90% of cases): Generalized tonic-clonic motor activity lasting < 15 minutes, occurring only once in a 24-hour period, followed by a brief postictal phase with a rapid return to baseline neurological status. Carries an excellent prognosis and does not cause permanent cognitive deficit, cerebral palsy, or epilepsy.
  • Complex Febrile Seizure: Focal motor activity, lasting > 15 minutes, or recurring within 24 hours. Requires urgent neuroimaging and electroencephalogram (EEG).

Emergency Nursing Interventions for an Active Febrile Seizure

Step-by-Step Nursing Actions During a Pediatric Seizure:
+--------------------------------------------------------------------------------+
| 1. Ensure Physical Safety: Lower the child to the floor or bed; clear hard,    |
|    sharp, or dangerous objects away; place a soft pad under the head.          |
| 2. Airway & Drainage: Roll the child onto their SIDE (lateral recovery        |
|    position) to allow saliva/vomitus to drain and prevent tongue occlusion.     |
| 3. Loosen Clothing: Loosen restrictive garments, ties, or buttons around neck. |
| 4. NEVER INSERT OBJECTS: DO NOT force anything into the child's mouth! No      |
|    tongue blades, spoons, fingers, or bite blocks (causes tooth fracture/choke)|
| 5. DO NOT RESTRAIN: Never pin or restrain extremities (causes bone fracture).  |
| 6. Time and Observe: Note exact onset, duration, and motor symmetry.          |
| 7. Pharmacological Rescue: If seizure persists > 5 minutes, administer         |
|    prescribed rescue anticonvulsant: Rectal Diazepam gel (0.2 to 0.5 mg/kg)    |
|    or Buccal / Intranasal Midazolam (0.2 mg/kg).                               |
+--------------------------------------------------------------------------------+